Haluk Tarık Kani

ORCID: 0000-0003-0042-9256
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Liver Disease and Transplantation
  • Colorectal Cancer Screening and Detection
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis C virus research
  • Liver Diseases and Immunity
  • Hepatitis B Virus Studies
  • Diverticular Disease and Complications
  • Nutrition and Health in Aging
  • Autoimmune and Inflammatory Disorders
  • Gastrointestinal disorders and treatments
  • Health Systems, Economic Evaluations, Quality of Life
  • Diet, Metabolism, and Disease
  • Sleep and related disorders
  • Pancreatitis Pathology and Treatment
  • COVID-19 diagnosis using AI
  • Gastroesophageal reflux and treatments
  • Diet and metabolism studies
  • Healthcare cost, quality, practices
  • Clinical Nutrition and Gastroenterology
  • Colorectal Cancer Treatments and Studies
  • Spondyloarthritis Studies and Treatments
  • Bariatric Surgery and Outcomes

Marmara University
2014-2025

New York University
2023

NYU Langone Health
2020-2021

Brooklyn Hospital Center
2021

European Foundation for the Study of Chronic Liver Failure
2021

CARE USA
2020

University of Pecs
2020

University of Debrecen
2020

Iuliu Hațieganu University of Medicine and Pharmacy
2020

University Gastroenterology
2019

Jonel Trebicka Javier Fernández Mária Papp Paolo Caraceni Wim Laleman and 95 more Carmine Gambino Ilaria Giovo Frank Erhard Uschner Christian Jansen César Jiménez Rajeshwar P. Mookerjee Thierry Gustot Agustı́n Albillos Rafael Bañares Peter Jarčuška Christian J. Steib Thomas Reiberger Juan Acevedo Pietro Gatti Debbie L. Shawcross Stefan Zeuzem Alexander Zipprich Salvatore Piano Thomas Berg Tony Bruns Karen Vagner Danielsen Minneke J. Coenraad Manuela Merli Rudolf Stauber Heinz Zoller José Presa Ramos Cristina Solé Germán Soriano Andrea De Gottardi Henning Grønbæk Faouzi Saliba Christian Trautwein Haluk Tarık Kani Sven Francque Stephen Ryder Pierre Nahon Manuel Romero‐Gómez Hans Van Vlierberghe Claire Francoz Michael P. Manns Elisabet García Manuel Tufoni Àlex Amorós Marco Pavesi Cristina Sánchez Michael Praktiknjo Anna Curto Carla Pitarch Antonella Putignano Esau Moreno William Bernal Ferrán Aguilar J. J. Clariá Paola Ponzo Zsuzsanna Vitális Giacomo Zaccherini Boglárka Balogh Alexander L. Gerbes Vı́ctor Vargas Carlo Alessandria Mauro Bernardi Pere Ginès Richard Moreau Paolo Angeli Rajiv Jalan Vicente Arroyo Miriam Maschmeier David Semela Laure Elkrief Ahmed M. Elsharkawy Tamás Tornai István Tornai I Altorjay Agnese Antognoli Maurizio Baldassarre Martina Gagliardi Eleonora Bertoli Sara Mareso Alessandra Brocca Daniela Campion Giorgio Maria Saracco Martina Rizzo Jennifer Lehmann Alessandra Pohlmann Maximilian Joseph Brol Johannes Chang Robert Schierwagen Elsa Solà Nesrine Amari Miguel Ángel Morán Rodríguez Frederik Nevens Ana Clemente Martin Janíčko Daniel Markwardt Mattias Mandorfer

Acute decompensation (AD) of cirrhosis may present without acute-on-chronic liver failure (ACLF) (AD-No ACLF), or with ACLF (AD-ACLF), defined by organ failure(s). Herein, we aimed to analyze and characterize the precipitants leading both these AD phenotypes. The multicenter, prospective, observational PREDICT study (NCT03056612) included 1,273 non-electively hospitalized patients (No = 1,071; 202). Medical history, clinical data laboratory were collected at enrolment during 90-day...

10.1016/j.jhep.2020.11.019 article EN cc-by-nc-nd Journal of Hepatology 2020-11-20

Abstract Background Azathioprine (AZA)-associated acute pancreatitis (AP) and gastrointestinal intolerance (GI-INT) are common causes of AZA discontinuation in IBD patients1,2. This study compares HLA alleles linked to AZA-AP3,4, along with demographic clinical data, between AP GI-INT patients. Methods Data from five centers were used form three groups: Control (n=88), AZA-AP (n=44), (n=44). Patients diagnosed during treatment per the Atlanta criteria (radiology, elevated amylase/lipase,...

10.1093/ecco-jcc/jjae190.1241 article EN Journal of Crohn s and Colitis 2025-01-01

Objective: Depression and anxiety are common disorders in inflammatory bowel disease (IBD). Our aim is to prospectively determine the effect of psychiatric treatment on scores for depression, anxiety, quality life (QoL), sexual dysfunction an outpatient population diagnosed with IBD also and/or depression disorder. Patients methods: who scored higher than cutoff point Hospital Anxiety Scale were referred further structured evaluation determination need drug treatment. underwent therapy...

10.2147/ndt.s106039 article EN cc-by-nc Neuropsychiatric Disease and Treatment 2016-03-01

Background/Aims: Advanced fibrosis (F≥3) indicates poor outcomes in nonalcoholic fatty liver disease (NAFLD).Here, we examined the diagnostic performance of fibrosis-4 index (FIB-4) and NAFLD score (NFS) for detecting (or excluding) advanced patients with biopsy-proven NAFLD.Methods: The each noninvasive test according to previously identified cutoff points indicating low high risk was determined 463 NAFLD.Patients who scored <1.3 >2.67 on FIB-4 were considered at fibrosis,...

10.5009/gnl19173 article EN cc-by-nc Gut and Liver 2019-09-18

SummaryBackgroundPatients with chronic gastrointestinal (GI) disease such as inflammatory bowel (IBD), irritable syndrome (IBS), celiac disease, gastroesophageal reflux (GERD), pancreatitis, and liver (CLD) often suffer from obesity because of coincidence (IBD, IBS, disease) or related pathophysiology (GERD, pancreatitis CLD). It is unclear if patients need a particular diagnostic treatment that differs the needs lean GI patients. The present guideline addresses this question according to...

10.1016/j.clnu.2022.07.003 article EN cc-by-nc-nd Clinical Nutrition 2022-08-12

Abstract Background This study aimed to determine the prevalence of probable sarcopenia and in patients with inflammatory bowel disease (IBD) by using European Working Group on Sarcopenia Older People (EWGSOP2) diagnostic criteria. Methods was assessed sequential four‐step algorithm. (1) Find: risk simple clinical symptom index (strength, assistance walking, rise from a chair, climb stairs, falls [SARC‐F questionnaire]). (2) Assess: Probable low muscle strength handgrip. (3) Confirm:...

10.1002/ncp.11125 article EN Nutrition in Clinical Practice 2024-02-06

Abstract Background Ulcerative colitis (UC) is a chronic inflammatory bowel disease with remissions and flares. Approximately 20% of UC Patients develop acute severe ulcerative (ASUC), serious condition that refractory to standard therapies leads morbidity mortality. Rescue therapy (salvage therapy) steroids, cyclosporine, and/or infliximab recommended by guidelines.1 The colectomy rate in ASUC remains at around 36% even the biological millennium.2 Upadacitinib (UPA) JAK1 selective inhibitor...

10.1093/ecco-jcc/jjae190.1189 article EN Journal of Crohn s and Colitis 2025-01-01

Abstract Background Patient-reported outcome measures (PROMs) are used to assess the effectiveness of treatments received by patients in terms clinical response inflammatory bowel disease (IBD). We aimed evaluate perceived from patient’s perspective using PRO2, IBD Control Questionnaire (ICQ) and Visual Analogue Scale (VAS) at end induction therapy treated with upadacitinib. also correlation PROMs biochemical response. Methods included who underwent upadacitinib 01/07/2024 01/10/2024 ten...

10.1093/ecco-jcc/jjae190.1283 article EN Journal of Crohn s and Colitis 2025-01-01

Abstract Background Crohn's disease (CD) is a chronic, remitting with sometimes inadequate response to the treatment and these factors may impact quality of life patients. Our study aims evaluate fistulizing disease, different options activity on in CD. Methods Patients who applied inflammatory bowel outpatient clinic between August 2021 September 2023 were invited respectively. agreed participate included study. The patients was assessed Inflammatory Bowel Disease Questionnaire (IBDQ),...

10.1093/ecco-jcc/jjae190.0736 article EN Journal of Crohn s and Colitis 2025-01-01

Abstract Background Strictures can be developed in approximately half of the Crohn’s disease (CD) patients during course disease. Stricturing CD treated by medical, endoscopic and surgical options. In this study, we investigated risk factors related surgery postoperative complications stricturing CD. Methods We included with who were followed up our inflammatory bowel specific outpatient clinic between 1989 2024. Demographic clinical data collected retrospectively from hospital electronic...

10.1093/ecco-jcc/jjae190.0654 article EN Journal of Crohn s and Colitis 2025-01-01

Abstract Background The best maintenance therapy after a steroid-responsive acute severe ulcerative colitis (ASUC) episode remains poorly studied and is not addressed in current guidelines. We aimed to compare the impact of different treatment strategies following hospitalization for ASUC. Methods Multicentric, multinational, retrospective cohort study including patients hospitalized with ASUC, between 2010-2021, who responded intravenous steroids (Oxford Criteria). Patients were categorized...

10.1093/ecco-jcc/jjae190.0140 article EN Journal of Crohn s and Colitis 2025-01-01

Clinical guidelines are a cornerstone of evidence-based medicine. Little is known about clinicians' knowledge guideline development and how they perceive quality. A survey protocol was designed according to the CHERRIES (improving quality web surveys: Checklist for Reporting Results Internet E-Surveys) checklist. The explored three main aspects: high-quality markers guidelines, development, areas improvement. conducted by contacting UEG affiliated societies email via social media. All valid...

10.1002/ueg2.70000 article EN cc-by United European Gastroenterology Journal 2025-02-28

Background/Aims: Nonalcoholic fatty liver disease (NAFLD), which consists of nonalcoholic (NAFL) and steatohepatitis (NASH), is a growing epidemic in Turkey, considering the recent alarming prevalence 48.3%.Patients with NASH and/or fibrosis are more likely to progress advanced disease.In this single-center study, we sought describe clinical histological characteristics sample Turkish patients biopsy-proven NAFLD, who were enrolled over 4-year period.Materials Methods: This retrospective...

10.5152/tjg.2019.19072 article EN The Turkish Journal of Gastroenterology 2019-06-26

Assessment of endoscopic activity in ulcerative colitis (UC) is important for treatment decisions and monitoring disease progress. However, substantial inter- intraobserver variability grading impairs the assessment. Our aim was to develop a computer-aided diagnosis system using deep learning reduce subjectivity improve reliability assessment.The cohort comprises 11 276 images from 564 patients who underwent colonoscopy UC. We propose regression-based approach evaluation UC according Mayo...

10.1093/ibd/izac226 article EN Inflammatory Bowel Diseases 2022-11-16

To determine the incidence rate and distribution of anemia types over time from an Inflammatory Bowel Disease (IBD) patient cohort spanning 18 years.Between January 1995 November 2013, University Hospital digital databases as well hard copies patients' files were reviewed retrospectively. IBD patients with at least one complete blood count (CBC) report included in this study.We obtained 941 records; 375 (39.9%) diagnosed Crohn's disease (CD), 566 (60.1%) had ulcerative colitis (UC). Anemia...

10.5152/tjg.2016.16011 article EN The Turkish Journal of Gastroenterology 2016-03-18

Hepatitis C virus (HCV) infection is known to impair the quality of life (QoL). Increased levels anxiety and depression have been found in HCV with a prevalence 28% 33%, respectively. Our aim was investigate depression, anxiety, QoL chronic hepatitis (CHC) patients before after treatment direct-acting antiviral agent (DAAA).In this study, enrolled CHC who had undergone DAAA our out-patient clinic. We administered Hospital Anxiety Depression (HAD) questionnaire measure severity symptoms Short...

10.5152/tjg.2019.18679 article EN The Turkish Journal of Gastroenterology 2019-09-16
Alexandra Demcsák Alexandra Soós L Kincses Inês Rita Capunge Georgi Minkov and 94 more Mila Kovacheva-Slavova Radislav Nakov Dong Wu Wei Huang Qing Xia Lihui Deng Marcus Hollenbach Alexander Schneider Michael Hirth Orestis Ioannidis Áron Vincze Judit Bajor Patrícia Sarlós László Czakó Dóra Illés Ferenc Izbéki László Gajdán Mária Papp József Hamvas Márta Varga Péter Kanizsai Ernő Bóna Alexandra Mikó Szilárd Váncsa Márk Juhász Klementina Ocskay Erika Darvasi Emőke Miklós Bálint Erőss Andrea Szentesi Andrea Párniczky Riccardo Casadei Claudio Ricci Carlo Ingaldi Laura Mastrangelo Elio Jovine Vincenzo Cennamo Marco V. Marino Giedrius Barauskas Povilas Ignatavičius Mario Peláez‐Luna Andrea Soriano Rios Svetlana Turcan Eugen Tcaciuc Ewa Małecka‐Panas Hubert Zatorski Vítor Nunes António Gomes Tiago Cúrdia Gonçalves Marta Freitas Júlio Constantino Milene Sá Jorge Pereira Bogdan Mateescu Gabriel Constantinescu Vasile Şandru Ionuţ Negoi Cezar Ciubotaru Valentina Madalina Negoita Ștefania Bunduc Cristian Gheorghe Sorin T. Barbu Alina Tanțău Marcel Tanțău Eugen Dumitru Andra‐Iulia Suceveanu Cristina Tocia Adriana Gherbon Andrey Litvin N. V. Shirinskaya Yu. S. Rabotyagova Mihailo Bezmarević Péter Hegyi Jimin Han Juan A. Rodríguez-Oballe Isabel Miguel Salas Eva Pijoan Comas Daniel de la Iglesia Andrea Jardi Cuadrado Adriano Quiroga Castiñeira Yu‐Ting Chang Ming-Chu Chang Ali Kchaou Ahmed Tlili Sabite Kaçar Volkan Gökbulut Deniz Duman Haluk Tarık Kani Engin Altıntaş S. Chooklin S.S. Chuklin Amir Gougol George Papachristou Péter Hegyi

Acid suppressing drugs (ASD) are generally used in acute pancreatitis (AP); however, large cohorts not available to understand their efficiency and safety. Therefore, our aims were evaluate the association between administration of ASDs, outcome AP, frequency gastrointestinal (GI) bleeding GI infection patients with AP. We initiated an international survey performed retrospective data analysis on AP hospitalized January 2013 December 2018. Data 17,422 adult collected from 59 centers 23...

10.1016/j.pan.2020.08.009 article EN cc-by-nc-nd Pancreatology 2020-08-22

10.5152/tjg.2024.23425 article EN The Turkish Journal of Gastroenterology 2024-01-05

BK-virus (BKV) is an important etiological agent for late-onset hemorrhagic cystitis (HC) in patients undergoing hematopoietic stem cell transplantation. Late-onset HC causes significant morbidity among these patients. Therapeutic approaches remain predominantly symptomatic. Several treatment options have been used with variable success rates. Cidofovir has the highest specificity against BKV; however, its lack of availability majority countries, high costs and potential nephrotoxic effects...

10.3892/ol.2014.2381 article EN Oncology Letters 2014-07-25
Coming Soon ...